Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 2
1957 1
1958 1
1959 3
1960 3
1961 3
1962 1
1963 2
1964 1
1965 1
1966 1
1967 1
1968 2
1969 1
1972 1
1973 1
1975 1
1978 1
1986 1
1988 6
1989 5
1990 7
1991 4
1992 5
1993 3
1994 2
1995 7
1996 2
1997 5
1998 4
1999 4
2000 2
2001 3
2002 1
2003 2
2004 6
2005 5
2006 8
2007 8
2008 12
2009 11
2010 15
2011 8
2012 9
2013 9
2014 6
2015 7
2016 5
2017 8
2018 8
2019 8
2020 15
2021 29
2022 15
2023 9
2024 11
2025 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

294 results

Results by year

Filters applied: . Clear all
Page 1
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study.
Castaigne S, Pautas C, Terré C, Raffoux E, Bordessoule D, Bastie JN, Legrand O, Thomas X, Turlure P, Reman O, de Revel T, Gastaud L, de Gunzburg N, Contentin N, Henry E, Marolleau JP, Aljijakli A, Rousselot P, Fenaux P, Preudhomme C, Chevret S, Dombret H; Acute Leukemia French Association. Castaigne S, et al. Lancet. 2012 Apr 21;379(9825):1508-16. doi: 10.1016/S0140-6736(12)60485-1. Epub 2012 Apr 5. Lancet. 2012. PMID: 22482940 Clinical Trial.
Effective targeting of PDGFRA-altered high-grade glioma with avapritinib.
Mayr L, Neyazi S, Schwark K, Trissal M, Beck A, Labelle J, Eder SK, Weiler-Wichtl L, Marques JG, de Biagi-Junior CAO, Lo Cascio C, Chapman O, Sridhar S, Kenkre R, Dutta A, Wang S, Wang J, Hack O, Nascimento A, Nguyen CM, Castellani S, Rozowsky JS, Groves A, Panditharatna E, Cruzeiro GAV, Haase RD, Tabatabai K, Madlener S, Wadden J, Adam T, Kong S, Miclea M, Patel T, Bruckner K, Senfter D, Lämmerer A, Supko J, Guntner AS, Palova H, Neradil J, Stepien N, Lötsch-Gojo D, Berger W, Leiss U, Rosenmayr V, Dorfer C, Dieckmann K, Peyrl A, Azizi AA, Baumgartner A, Slaby O, Pokorna P, Clark LM, Cameron A, Nguyen QD, Wakimoto H, Dubois F, Greenwald NF, Bandopadhayay P, Beroukhim R, Ligon K, Kramm C, Bronsema A, Bailey S, Stucklin AG, Mueller S, Skrypek M, Martinez N, Bowers DC, Jones DTW, Jones C, Jäger N, Sterba J, Müllauer L, Haberler C, Kumar-Sinha C, Chinnaiyan A, Mody R, Chavez L, Furtner J, Koschmann C, Gojo J, Filbin MG. Mayr L, et al. Cancer Cell. 2025 Apr 14;43(4):740-756.e8. doi: 10.1016/j.ccell.2025.02.018. Epub 2025 Mar 13. Cancer Cell. 2025. PMID: 40086436
Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia.
Chalandon Y, Thomas X, Hayette S, Cayuela JM, Abbal C, Huguet F, Raffoux E, Leguay T, Rousselot P, Lepretre S, Escoffre-Barbe M, Maury S, Berthon C, Tavernier E, Lambert JF, Lafage-Pochitaloff M, Lhéritier V, Chevret S, Ifrah N, Dombret H; Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL). Chalandon Y, et al. Blood. 2015 Jun 11;125(24):3711-9. doi: 10.1182/blood-2015-02-627935. Epub 2015 Apr 15. Blood. 2015. PMID: 25878120 Free article. Clinical Trial.
The European reference network for metabolic diseases (MetabERN) clinical pathway recommendations for Pompe disease (acid maltase deficiency, glycogen storage disease type II).
Parenti G, Fecarotta S, Alagia M, Attaianese F, Verde A, Tarallo A, Gragnaniello V, Ziagaki A, Guimaraes MJ, Aguiar P, Hahn A, Azevedo O, Donati MA, Kiec-Wilk B, Scarpa M, van der Beek NAME, Del Toro Riera M, Germain DP, Huidekoper H, van den Hout JMP, van der Ploeg AT; and the MetabERN Subnetwork for Lysosomal Disorders. Parenti G, et al. Orphanet J Rare Dis. 2024 Nov 1;19(1):408. doi: 10.1186/s13023-024-03373-w. Orphanet J Rare Dis. 2024. PMID: 39482698 Free PMC article. Review.
Cardiovascular manifestations in Marfan syndrome.
Lazea C, Bucerzan S, Crisan M, Al-Khzouz C, Miclea D, Şufană C, Cismaru G, Grigorescu-Sido P. Lazea C, et al. Med Pharm Rep. 2021 Aug;94(Suppl No 1):S25-S27. doi: 10.15386/mpr-2223. Epub 2021 Aug 10. Med Pharm Rep. 2021. PMID: 34527904 Free PMC article.
Prostatic blue nevus.
Anderco D, Lazăr E, Tăban S, Miclea F, Dema A. Anderco D, et al. Rom J Morphol Embryol. 2010;51(3):555-7. Rom J Morphol Embryol. 2010. PMID: 20809037 Free article.
Single-molecule systems for the detection and monitoring of plasma-circulating nucleosomes and oncoproteins in diffuse midline glioma.
Erez N, Furth N, Fedyuk V, Wadden J, Aittaleb R, Adam T, Schwark K, Niculcea M, Miclea M, Mody R, Franson A, Parmar HA, Ibrahim M, Lau B, Eze A, Nourmohammadi N, Fried I, Nazarian J, Ron G, Venneti S, Koschmann C, Shema E. Erez N, et al. Cell Rep Med. 2025 Jan 21;6(1):101918. doi: 10.1016/j.xcrm.2024.101918. Epub 2025 Jan 13. Cell Rep Med. 2025. PMID: 39809263 Free PMC article.
46,XX DSD: Developmental, Clinical and Genetic Aspects.
Alkhzouz C, Bucerzan S, Miclaus M, Mirea AM, Miclea D. Alkhzouz C, et al. Diagnostics (Basel). 2021 Jul 30;11(8):1379. doi: 10.3390/diagnostics11081379. Diagnostics (Basel). 2021. PMID: 34441313 Free PMC article. Review.
Prognosis Communication in Pediatric Oncology: A Systematic Review.
Boeriu E, Borda A, Miclea E, Boeriu AI, Vulcanescu DD, Bagiu IC, Horhat FG, Kovacs AF, Avram CR, Diaconu MM, Vlaicu LF, Sirb OD, Arghirescu ST. Boeriu E, et al. Children (Basel). 2023 May 30;10(6):972. doi: 10.3390/children10060972. Children (Basel). 2023. PMID: 37371204 Free PMC article. Review.
294 results